Ann Dermatol.
2023 Apr;35(2):158-160. 10.5021/ad.20.327.
Recurrent Esophageal Candidiasis Induced by Secukinumab: Discrepancy between Clinical Trials and Real-World Data
- Affiliations
-
- 1Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, Korea
- KMID: 2541121
- DOI: http://doi.org/10.5021/ad.20.327
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Recurrent Esophageal Stricture Caused by Candidiasis in an HIV-Infected Patient
- Esophagus, Stomach & Intestine; A Case of Esophageal Candidiasis Presenting Recurrent Abdominal Pain in an Immunocompetent Child
- Safety of Adalimumab, Ustekinumab, Secukinumab, Guselkumab in Korean Patients with Moderate to Severe Psoriasis: A Real-World Data in a Single Medical Center
- Abrupt Development of Esophageal Candidiasis after Secukinumab Treatment in a Psoriatic Patient
- A case of esophageal candidiasis caused by inhaled corticosteroid
